The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Neuropharmacological Profile of Novel and Selective 5-HT6 Receptor Agonists: WAY-181187 and WAY-208466
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Role of Neurotrophic Factors in the Etiology and Treatment of Mood Disorders
Duman, R. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:011 · Cited by 537
Glutamate and Depression: Clinical and Preclinical Studies
PAUL, I. A., & SKOLNICK, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.016 · Cited by 408 · cited 1×
“…implicating glutamate in affective disorders, including depression, have shown that dampening glutamatergic transmission via NMDA receptor antagonists elicits antidepressant-like activity in preclinical behavioral models of depression (reviewed in Paul and Skolnick, 2003; Yilmaz et al, 2002).”
Noradrenergic Excitation and Inhibition of GABAergic Cell Types in Rat Frontal Cortex
Kawaguchi, Y., & Shindou, T. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-17-06963.1998 · Cited by 230 · cited 2×
“Certainly, the strategic localization of serotonergic or noradrenergic neurons and their effects on GABAergic neurotransmission are well documented (Doze et al, 1991; Kawaguchi and Shindou, 1998; Smiley and Goldman-Rakic, 1996).”
Hamon, M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00044-5 · Cited by 191 · cited 2×
“This hypothesis is further strengthened by previous behavioral work showing that downregulation of 5-HT6 receptor expression (via antisense oligonucleotides) is anxiogenic in two models of anxiety (Hamon et al, 1999; Otano et al, 1999).”
Cited by
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory
KING, M., MARSDEN, C., & FONE, K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.07.001 · Cited by 304
Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease
Xu, Y., Yan, J., Zhou, P., Li, J., Gao, H., Xia, Y., & Wang, Q. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.02.002 · Cited by 301
Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
5-HT6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's Disease
Upton, N., Chuang, T. T., Hunter, A. J., & Virley, D. J. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.008 · Cited by 255
A serotonergic axon-cilium synapse drives nuclear signaling to alter chromatin accessibility
Sheu, S.-H., Upadhyayula, S., Dupuy, V., Pang, S., Deng, F., Wan, J., Walpita, D., Pasolli, H. A., Houser, J., Sanchez-Martinez, S., et al. (2022) · Cell · doi:10.1016/j.cell.2022.07.026 · Cited by 162
“As Htr6 transcripts in the hippocampus are not detectable until (cid:1) P14 (Thompson et al., 2014), this altered pattern most likely occurs in the late postnatal period or early adulthood.”
Role of Serotonin in Alzheimerʼs Disease: A New Therapeutic Target?
Geldenhuys, W. J., & Van der Schyf, C. J. (2011) · CNS Drugs · doi:10.2165/11590190-000000000-00000 · Cited by 117
Serotoninergic mechanisms in the treatment of obsessive–compulsive disorder
Goddard, A. W., Shekhar, A., Whiteman, A. F., & McDougle, C. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.12.009 · Cited by 112
Więckowska, A., Kołaczkowski, M., Bucki, A., Godyń, J., Marcinkowska, M., Więckowski, K., Zaręba, P., Siwek, A., Kazek, G., Głuch-Lutwin, M., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.016 · Cited by 91
Acute EPA-induced learning and memory impairment in mice is prevented by DHA
Liu, J.-H., Wang, Q., You, Q.-L., Li, Z.-L., Hu, N.-Y., Wang, Y., Jin, Z.-L., Li, S.-J., Li, X.-W., Yang, J.-M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19255-1 · Cited by 77
Serotonin 6 receptor controls alzheimer’s disease and depression
Yun, H.-M., Park, K.-R., Kim, E.-C., Kim, S., & Hong, J. T. (2015) · Oncotarget · doi:10.18632/oncotarget.5777 · Cited by 62
de Bruin, N. M. W. J., van Loevezijn, A., Wicke, K. M., de Haan, M., Venhorst, J., Lange, J. H. M., de Groote, L., van der Neut, M. A. W., Prickaerts, J., Andriambeloson, E., et al. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.06.020 · Cited by 22
“…shown to result in the modulation of several neurotransmitter systems potentially explaining the robust activity that has been observed for 5-HT6 receptor antagonists in preclinical models of cognition (Dawson, Nguyen, & Li, 2001; Lacroix, Dawson, Hagan, & Heidbreder, 2004; Schechter et al., 2008).”
BackgroundSerotonin signaling at cilia synapses
DeLong, K., & Sheu, S.-H. (2025) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2025.102994 · Cited by 7
Metadata
- Authors
- Schechter, L. E., Lin, Q., Smith, D. L., Zhang, G., Shan, Q., Platt, B., Brandt, M. R., Dawson, L. A., Cole, D., Bernotas, R., Robichaud, A., Rosenzweig-Lipson, S., & Beyer, C. E.
- Venue
- Neuropsychopharmacology
- Published
- 2007-07-11
- Volume
- 33
- Issue
- 6
- Pages
- 1323-1335
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2011880726
- Cited by
- 222
- References
- 6
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.